Bone Mineral Density in Postmenopausal Women Heterozygous for the C282Y HFE Mutation

por Gunton, Jenny E., Gates, Frances, Fulcher, Greg R., Clifton-Bligh, Phillip B.
Publicado 2016

Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials

por Fulcher, Greg, Mehta, Roopa, Fita, Edmond G., Ekelund, Magnus, Bain, Stephen C.
Publicado 2018

The co‐formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia, independent of baseline glycated haemogl...

por Haluzík, Martin, Fulcher, Greg, Pieber, Thomas R., Bardtrum, Lars, Tutkunkardas, Deniz, Rodbard, Helena W.
Publicado 2018

Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes

por Wu, Ted, Betty, Bryan, Downie, Michelle, Khanolkar, Manish, Kilov, Gary, Orr-Walker, Brandon, Senator, Gordon, Fulcher, Greg
Publicado 2015

The Clinical Role of Insulin Degludec/Insulin Aspart in Type 2 Diabetes: An Empirical Perspective from Experience in Australia

por Glastras, Sarah J., Cohen, Neale, Dover, Thomas, Kilov, Gary, MacIsaac, Richard J., McGill, Margaret, Fulcher, Greg R.
Publicado 2020

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Interven...

por Scott, Russell, O'Brien, Richard, Fulcher, Greg, Pardy, Chris, d'Emden, Michael, Tse, Dana, Taskinen, Marja-Riitta, Ehnholm, Christian, Keech, Anthony
Publicado 2009

Primary and tertiary health professionals’ views on the health-care of patients with co-morbid diabetes and chronic kidney disease – a qualitative study

por Lo, Clement, Ilic, Dragan, Teede, Helena, Fulcher, Greg, Gallagher, Martin, Kerr, Peter G, Murphy, Kerry, Polkinghorne, Kevan, Russell, Grant, Usherwood, Timothy, Walker, Rowan, Zoungas, Sophia
Publicado 2016

The association between patient activation and self‐care practices: A cross‐sectional study of an Australian population with comorbid diabetes and chronic kidney disease

por Zimbudzi, Edward, Lo, Clement, Ranasinha, Sanjeeva, Kerr, Peter G, Polkinghorne, Kevan R, Teede, Helena, Usherwood, Timothy, Walker, Rowan G, Johnson, Greg, Fulcher, Greg, Zoungas, Sophia
Publicado 2017

Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program

por Wang, Katherine M., Li, JingWei, Bhalla, Vivek, Jardine, Meg J., Neal, Bruce, de Zeeuw, Dick, Fulcher, Greg, Perkovic, Vlado, Mahaffey, Kenneth W., Chang, Tara I.
Publicado 2021

The Perspectives of Patients on Health-Care for Co-Morbid Diabetes and Chronic Kidney Disease: A Qualitative Study

por Lo, Clement, Ilic, Dragan, Teede, Helena, Cass, Alan, Fulcher, Greg, Gallagher, Martin, Johnson, Greg, Kerr, Peter G., Mathew, Tim, Murphy, Kerry, Polkinghorne, Kevan, Walker, Rowan, Zoungas, Sophia
Publicado 2016

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)

por Mahaffey, Kenneth W., Neal, Bruce, Perkovic, Vlado, de Zeeuw, Dick, Fulcher, Greg, Erondu, Ngozi, Shaw, Wayne, Fabbrini, Elisa, Sun, Tao, Li, Qiang, Desai, Mehul, Matthews, David R.
Publicado 2018

Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS‐R trials

por Neal, Bruce, Perkovic, Vlado, Mahaffey, Kenneth W., Fulcher, Greg, Erondu, Ngozi, Desai, Mehul, Shaw, Wayne, Law, Gordon, Walton, Marc K., Rosenthal, Norm, de Zeeuw, Dick, Matthews, David R.
Publicado 2017

Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program

por Zhou, Zien, Jardine, Meg, Perkovic, Vlado, Matthews, David R., Mahaffey, Kenneth W., de Zeeuw, Dick, Fulcher, Greg, Desai, Mehul, Oh, Richard, Simpson, Roger, Watts, Nelson B., Neal, Bruce
Publicado 2019

Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial

por Fulcher, Greg, Matthews, David R., Perkovic, Vlado, de Zeeuw, Dick, Mahaffey, Kenneth W., Weiss, Robert, Rosenstock, Julio, Capuano, George, Desai, Mehul, Shaw, Wayne, Vercruysse, Frank, Meininger, Gary, Neal, Bruce
Publicado 2015

Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS‐R): A randomized, placebo‐controlled trial

por Neal, Bruce, Perkovic, Vlado, Matthews, David R., Mahaffey, Kenneth W., Fulcher, Greg, Meininger, Gary, Erondu, Ngozi, Desai, Mehul, Shaw, Wayne, Vercruysse, Frank, Yee, Jacqueline, Deng, Hsiaowei, de Zeeuw, Dick
Publicado 2017

Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program

por Rådholm, Karin, Figtree, Gemma, Perkovic, Vlado, Solomon, Scott D., Mahaffey, Kenneth W., de Zeeuw, Dick, Fulcher, Greg, Barrett, Terrance D., Shaw, Wayne, Desai, Mehul, Matthews, David R., Neal, Bruce
Publicado 2018

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

por Matthews, David R., Li, Qiang, Perkovic, Vlado, Mahaffey, Kenneth W., de Zeeuw, Dick, Fulcher, Greg, Desai, Mehul, Hiatt, William R., Nehler, Mark, Fabbrini, Elisa, Kavalam, Mary, Lee, Mary, Neal, Bruce
Publicado 2019

Canagliflozin and Stroke in Type 2 Diabetes Mellitus: Results From the Randomized CANVAS Program Trials

por Zhou, Zien, Lindley, Richard I., Rådholm, Karin, Jenkins, Bronwyn, Watson, John, Perkovic, Vlado, Mahaffey, Kenneth W., de Zeeuw, Dick, Fulcher, Greg, Shaw, Wayne, Oh, Richard, Desai, Mehul, Matthews, David R., Neal, Bruce
Publicado 2019

Health-related quality of life among patients with comorbid diabetes and kidney disease attending a codesigned integrated model of care: a longitudinal study

por Zimbudzi, Edward, Lo, Clement, Ranasinha, Sanjeeva, Teede, Helena, Usherwood, Tim, Polkinghorne, Kevan R, Fulcher, Greg, Gallagher, Martin, Jan, Steven, Cass, Alan, Walker, Rowan, Russell, Grant, Johnson, Greg, Kerr, Peter G, Zoungas, Sophia
Publicado 2020

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes

por Neuen, Brendon L., Arnott, Clare, Perkovic, Vlado, Figtree, Gemma, de Zeeuw, Dick, Fulcher, Greg, Jun, Min, Jardine, Meg J., Zoungas, Sophia, Pollock, Carol, Mahaffey, Kenneth W., Neal, Bruce, Heerspink, Hiddo J. L.
Publicado 2020